Researchers examine factors that could help clinicians identify patients with the highest risk of fatal anaphylaxis. A report published in Allergy identified the knowledge gaps that should be ...
Researchers have characterized common adverse reactions to combination lenvatinib and pembrolizumab in patients with advanced renal cell carcinoma. Researchers have characterized common adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results